Both in Pharmaceuticals
Opus Genetics vs ARS Pharmaceuticals
Over the past year IRD returned +72.4% and SPRY returned −64.6%; their daily moves had a correlation of 0.11.
IRD +72.4% SPRY −64.6%Growth of $1, one year, split-adjusted
| Metric | IRD | SPRY |
|---|---|---|
| Price | $3.69 | $3.05 |
| Market cap | $307.0M | $303.3M |
| Today | +0.55% | −9.76% |
| 1 month | −19.4% | −25.1% |
| 6 months | −29.3% | −65.5% |
| Year to date | +83.6% | −73.8% |
| 1 year | +87.3% | −64.6% |
| Revenue growth (YoY) | −73.8% | +114.2% |
| Gross margin | 100.0% | 61.8% |
| Net margin | −1072.6% | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | 31.1× | 2.6× |
| Net cash | $53.9M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 91.9% | 70.2% |
| Short % of float | 21.4% | 40.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).